![David A. Burns](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David A. Burns
Chief Executive Officer at Cellectricon AB
David A. Burns active positions
Companies | Position | Start | End |
---|---|---|---|
Cellectricon AB
![]() Cellectricon AB Miscellaneous Commercial ServicesCommercial Services Cellectricon AB provides cell-based screening services to accelerate drug discovery. The firm develops and validates exciting central nervous system and peripheral pain assays using primary cells, accelerating the path from assay validation to compound screening. Its system is equipped with an imaging-based microplate reader to simultaneously record transient fluorescence and luminescence signals, providing real-time monitoring and readouts of cell culture response. The company was founded by Jan Owe Owesson Orwar, Daniel T. Chiu and Stig Anders Jakob Lindberg in 1999 and is headquartered in Molndal, Sweden. | Director/Board Member | 2011-09-19 | - |
Chief Executive Officer | 2011-09-20 | - |
Career history of David A. Burns
Former positions of David A. Burns
Companies | Position | Start | End |
---|---|---|---|
Packard BioScience Co.
![]() Packard BioScience Co. Medical SpecialtiesHealth Technology On July 13, 2001, the company entered into a merger agreement with PerkinElmer, Inc. Pursuant to the merger agreement, the company will become a subsidiary of PerkinElmer and each outstanding share of the company's common stock will be converted into 0.311 of a share of PerkinElmer common stock | Corporate Officer/Principal | - | - |
Isogenica Ltd.
![]() Isogenica Ltd. Miscellaneous Commercial ServicesCommercial Services Isogenica Ltd. provides research and development services in the fields of new peptide, antibody and other polypeptide drug candidates. It offers llamdA System, Xab System and 4D Fab System. The company was founded by Kevin Fitzgerald in 2000 and is headquartered in Little Chesterford, the United Kingdom. | Director/Board Member | - | - |
PerkinElmer BioSignal, Inc.
![]() PerkinElmer BioSignal, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Revvity, Inc., PerkinElmer BioSignal, Inc. develops and markets cloned drug targets as drug screening reagents. The company is based in Montréal, Canada. | Sales & Marketing | - | - |
GE Healthcare Niagara, Inc. | Chief Executive Officer | - | - |
Renishaw Diagnostics Ltd.
![]() Renishaw Diagnostics Ltd. Medical SpecialtiesHealth Technology Renishaw Diagnostics Ltd. provides diagnostic services to detect infectious diseases. The company is headquartered in Edinburgh, the United Kingdom. | Chief Executive Officer | - | - |
Pharmacia LKB Biotechnology, Inc. | Corporate Officer/Principal | - | - |
Hammersmith Imanet Ltd. | President | - | - |
GE UK Group
![]() GE UK Group MiscellaneousMiscellaneous Part of GE Aerospace, GE UK Group is an investment holding company. GE UK Group is based in Altrincham, UK. The British company was founded in 2008. The CEO is Kevin Michael O'Neill. | Corporate Officer/Principal | - | - |
░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░ ░ ░░░░░░░░░ | ░░░░░░░░░░ | - |
Training of David A. Burns
Napier University | Undergraduate Degree |
Statistics
International
United Kingdom | 6 |
United States | 4 |
Canada | 3 |
Operational
Chief Executive Officer | 3 |
Corporate Officer/Principal | 3 |
Sales & Marketing | 2 |
Sectoral
Commercial Services | 5 |
Health Technology | 3 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 10 |
---|---|
Cyntellect, Inc.
![]() Cyntellect, Inc. Miscellaneous Commercial ServicesCommercial Services Cyntellect, Inc. develops life science technologies. Its products supported key applications to advance life science research, biopharmaceutical production, and stem cell research and drug discovery. The company was founded by Paul R. Billings, Manfred R. Koller and Bernhard O. Palsson in 1997 and was headquartered in San Diego, CA. | Commercial Services |
GE UK Group
![]() GE UK Group MiscellaneousMiscellaneous Part of GE Aerospace, GE UK Group is an investment holding company. GE UK Group is based in Altrincham, UK. The British company was founded in 2008. The CEO is Kevin Michael O'Neill. | Miscellaneous |
Hammersmith Imanet Ltd. | |
Pharmacia LKB Biotechnology, Inc. | |
Cellectricon AB
![]() Cellectricon AB Miscellaneous Commercial ServicesCommercial Services Cellectricon AB provides cell-based screening services to accelerate drug discovery. The firm develops and validates exciting central nervous system and peripheral pain assays using primary cells, accelerating the path from assay validation to compound screening. Its system is equipped with an imaging-based microplate reader to simultaneously record transient fluorescence and luminescence signals, providing real-time monitoring and readouts of cell culture response. The company was founded by Jan Owe Owesson Orwar, Daniel T. Chiu and Stig Anders Jakob Lindberg in 1999 and is headquartered in Molndal, Sweden. | Commercial Services |
Renishaw Diagnostics Ltd.
![]() Renishaw Diagnostics Ltd. Medical SpecialtiesHealth Technology Renishaw Diagnostics Ltd. provides diagnostic services to detect infectious diseases. The company is headquartered in Edinburgh, the United Kingdom. | Health Technology |
PerkinElmer BioSignal, Inc.
![]() PerkinElmer BioSignal, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Revvity, Inc., PerkinElmer BioSignal, Inc. develops and markets cloned drug targets as drug screening reagents. The company is based in Montréal, Canada. | Commercial Services |
GE Healthcare Niagara, Inc. | |
Packard BioScience Co.
![]() Packard BioScience Co. Medical SpecialtiesHealth Technology On July 13, 2001, the company entered into a merger agreement with PerkinElmer, Inc. Pursuant to the merger agreement, the company will become a subsidiary of PerkinElmer and each outstanding share of the company's common stock will be converted into 0.311 of a share of PerkinElmer common stock | Health Technology |
Isogenica Ltd.
![]() Isogenica Ltd. Miscellaneous Commercial ServicesCommercial Services Isogenica Ltd. provides research and development services in the fields of new peptide, antibody and other polypeptide drug candidates. It offers llamdA System, Xab System and 4D Fab System. The company was founded by Kevin Fitzgerald in 2000 and is headquartered in Little Chesterford, the United Kingdom. | Commercial Services |
- Stock Market
- Insiders
- David A. Burns
- Experience